HomeREGULATORY
REGULATORY

Chuikyo Rep Frowns on Low Manufacturing Cost Disclosure, Says New Rule Might Need Revisiting
(May.17.2018)

Bill Payer Reps Toshikazu Yoshimori (left), Shoji Kono
A vocal payer rep of the Central Social Insurance Medical Council, better known as Chuikyo, on May 16 threw doubt on the effectiveness of a new coefficient rule introduced this April that might reduce drug prices based on how much cost information manufacturers disclose ...
(LOG IN FOR FULL STORY)